Get the Stockscreener App
2.4797
3.39%
-0.0903
Inovio Pharmaceuticals Inc stock is traded at $2.4797, with a volume of 166.93K.
It is down -3.39% in the last 24 hours and up +4.33% over the past month.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
See More
Previous Close:
$2.57
Open:
$2.59
24h Volume:
166.93K
Relative Volume:
0.10
Market Cap:
$131.79M
Revenue:
$832.00K
Net Income/Loss:
$-135.12M
P/E Ratio:
-0.4072
EPS:
-6.09
Net Cash Flow:
$-124.69M
1W Performance:
+3.03%
1M Performance:
+4.33%
6M Performance:
+54.22%
1Y Performance:
-56.82%
1-Day Range:
$2.47
$2.63
1-Week Range:
$2.28
$2.68
52-Week Range:
$1.30
$5.83
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Name
Inovio Pharmaceuticals Inc
Sector
Industry
Phone
(858) 410-3134
Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.48 | 136.58M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.42 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.45 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.17 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.67 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-14-24 | Initiated | Stephens | Overweight |
| Jan-25-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-09-22 | Downgrade | Maxim Group | Buy → Hold |
| Nov-01-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-19-22 | Resumed | RBC Capital Mkts | Sector Perform |
| May-11-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-29-21 | Resumed | Jefferies | Hold |
| Sep-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-24-21 | Initiated | Jefferies | Hold |
| Mar-23-21 | Initiated | BofA Securities | Neutral |
| Feb-12-21 | Initiated | Oppenheimer | Outperform |
| Nov-17-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Nov-10-20 | Upgrade | ROTH Capital | Sell → Neutral |
| Sep-28-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-28-20 | Upgrade | Maxim Group | Hold → Buy |
| Jul-01-20 | Downgrade | Maxim Group | Buy → Hold |
| Jul-01-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Jun-29-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-26-20 | Downgrade | Stifel | Buy → Hold |
| May-21-20 | Initiated | The Benchmark Company | Buy |
| Apr-30-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Mar-13-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-13-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-19-19 | Initiated | ROTH Capital | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
| Oct-18-17 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-17 | Initiated | Citigroup | Buy |
| Jun-08-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-24-17 | Reiterated | Maxim Group | Buy |
| Mar-16-17 | Upgrade | Maxim Group | Hold → Buy |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
View All
Inovio Pharmaceuticals Inc Stock (INO) Latest News
Will Inovio Pharmaceuticals Inc. bounce back from current supportJuly 2025 Gainers & Weekly Return Optimization Alerts - newser.com
What momentum indicators show for Inovio Pharmaceuticals Inc. stock2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com
Is Inovio Pharmaceuticals Inc. building a consolidation baseWeekly Investment Recap & Advanced Technical Signal Analysis - newser.com
Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Inovio Pharmaceuticals : American Academy of Otolaryngology – Head and Neck Surgery Annual Meeting Abstract - MarketScreener
Is Inovio Pharmaceuticals Inc. (GBM) stock prepared for digital transitionWeekly Gains Report & Community Verified Trade Alerts - newser.com
A activity2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
How to track smart money flows in Inovio Pharmaceuticals Inc.2025 Big Picture & Entry and Exit Point Strategies - newser.com
Inovio Pharmaceuticals' (INO) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Inovio Pharmaceuticals Inc. Stock Climbs 7.1%, Outperforms Peers - 富途牛牛
What drives Inovio Pharmaceuticals Inc GBM stock priceBollinger Bands Signals & Free Phenomenal Capital Appreciation - earlytimes.in
INOVIO Announces Equity Grant Under 2022 Inducement Plan - MSN
Can Akar Auto Industries Limited Achieve Earnings Growth in a SlowdownVWAP Trading Strategies & High Profit Investment Ideas - earlytimes.in
Inovio Pharmaceuticals (NASDAQ:INO) Share Price Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Can Inovio Pharmaceuticals Inc. stock beat analyst upgradesTrade Ideas & Fast Moving Stock Watchlists - newser.com
Is Inovio Pharmaceuticals Inc. (GBM) stock trading at attractive multiplesShare Buyback & Reliable Intraday Trade Plans - newser.com
When is the best time to exit Inovio Pharmaceuticals Inc.Product Launch & Verified Momentum Stock Alerts - newser.com
Will Inovio Pharmaceuticals Inc. stock remain a Wall Street favoriteJuly 2025 Macro Moves & Accurate Intraday Trade Tips - newser.com
Technical analysis overview for Inovio Pharmaceuticals Inc. stockGlobal Markets & Daily Technical Forecast Reports - newser.com
INOVIO Reports Inducement Grant Under Inducement Plan - Eastern Progress
Is Inovio Pharmaceuticals Inc. stock a top momentum play2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Inovio Pharmaceuticals Inc. stock trendline breakdownWeekly Trade Review & Detailed Earnings Play Alerts - newser.com
What hedge fund moves indicate for Inovio Pharmaceuticals Inc. (GBM) stock2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
Heatmap analysis for Inovio Pharmaceuticals Inc. and competitorsGold Moves & Growth Focused Stock Pick Reports - newser.com
INOVIO to Present Key Data on DNA Medicines at Global Scientific Conferences - MyChesCo
Certain Stock Options of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 1-OCT-2025. - MarketScreener
Certain Common Stock of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 1-OCT-2025. - MarketScreener
Non-Viral Transfection Reagents Industry Report 2025, with Profiles of Altogen Biosystems, BEX, BTX, Celsion, Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene, OZ Biosciences & MoreResearchAndMarkets.com - The AI Journal
What analysts say about Inovio Pharmaceuticals Inc GBM stockVolume Profile Analysis & Watch These Before They Go Viral - earlytimes.in
Key Metrics Every Investor Should Know About Soni Medicare LimitedProtective Put Strategies & Exceptional Capital Growth - earlytimes.in
How moving averages guide Inovio Pharmaceuticals Inc. tradingMarket Weekly Review & Weekly Top Stock Performers List - newser.com
Inovio Pharmaceuticals Inc Stock (INO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):